A cancer diagnosis can shatter your world, and sharing that news with loved ones is an emotional rollercoaster. At 44, I received the unexpected blow of colon cancer, a disease I thought was reserved for the elderly. But I'm not alone; colorectal cancer is increasingly affecting younger generations, a worrying trend. The average age for a colon cancer diagnosis in men is 66, but I'm living proof that it can strike much earlier.
The Shocking Diagnosis:
As I sat in a cab, post-colonoscopy, I struggled to find the words to tell my wife. I felt numb, not devastated as the media portrays. My only symptom, blood in my stool, was easily overlooked, but I'm grateful I paid attention. The news came in August 2023, and I was relatively healthy, hitting the gym and running marathons. But cancer doesn't discriminate.
The Long Road to Recovery:
I underwent a six-hour surgery, followed by 12 rounds of chemotherapy with Oxaliplatin, a potent drug. Just when I thought the worst was over, another surgery on my liver was needed. It's been a challenging journey, but I'm in a good place now, with no evidence of disease for over a year.
A Rising Concern:
Colorectal cancer is on the rise among young people, including Generation Z, millennials, and Generation X. This trend is concerning, especially with federal budget cuts threatening cancer research. The Trump administration's crackdown on 'woke' initiatives and Health Secretary Robert F. Kennedy Jr.'s anti-science beliefs have jeopardized funding for crucial studies.
The Expert's Perspective:
Dr. John Marshall, a leading oncologist, explains that those affected are often health-conscious individuals in their 30s and 40s. They exercise, watch their diets, and are attuned to their bodies. The phrase 'young onset' is becoming more common, with celebrities like James Van Der Beek and Chadwick Boseman diagnosed in their 40s.
A Disturbing Trend:
The death rate from colorectal cancer has been falling in older adults but rising in younger ones since the mid-2000s. Cases among 20 to 34-year-olds are projected to increase by 90% by 2030. Experts believe changes in gut bacteria, influenced by diet, antibiotics, and environmental factors, may play a role.
The Treatment Gap:
Despite the increasing incidence, treatments for young patients haven't evolved much. Twenty-somethings receive the same care as older patients did decades ago. Breast cancer, for instance, has seen significant advancements in treatment and cure rates, while colorectal cancer seems frozen in time.
The Role of Federal Funding:
Federal government funding is vital for cancer research, as it supports studies that the pharmaceutical industry might not prioritize. The National Institutes of Health (NIH) has faced funding cuts, with over 100 canceled grants for cancer research. Senator Bernie Sanders argues that these cuts are an attack on those affected by cancer.
The Impact of Budget Cuts:
The Trump administration aims to reduce the NIH's budget by nearly 40%, a move criticized by cancer campaigners and experts. Federally funded research has led to groundbreaking discoveries, such as immunotherapy, which the industry then monetizes. Without this funding, innovation could grind to a halt.
Hope in the Face of Adversity:
Federal government backing provides cancer patients with hope, something invaluable. Emerging treatments for colorectal cancer offer promise, but budget cuts threaten their development. Patients like Liz Healy, diagnosed with colorectal and kidney cancer, and Jessica Acosta, who benefited from immunotherapy, highlight the importance of continued research.
The Human Side of Cancer:
Cancer is a lonely battle, with the physical toll of treatment and the emotional weight of others' reactions. Humor becomes a coping mechanism. Diana Zepeda, diagnosed at 33, uses humor to navigate her journey. She's grateful for past advancements but eagerly awaits a cure, hoping to live long enough to see it.
The Fight for Funding:
Marissa Lio, who lost her husband Micah to colorectal cancer, advocates for private funding to offset federal cuts. Micah, a vibrant and healthy 33-year-old, succumbed to the disease due to limited treatment options. His story, like many others, underscores the urgency of continued research and funding.
A Call to Action:
Bravery is admirable, but it's science that will deliver life-saving treatments. We must advocate for federal funding to ensure that research continues, giving hope to those affected by cancer. The battle against cancer is far from over, and every voice counts in this fight. Are we willing to let budget cuts hinder our progress? It's a question that demands our attention and action.
